Form 13-F position report

BAUSCH HEALTH COMPANIES INC CO

Reported by Chou Associates Management Inc

BHC CUSIP 071734107 Manager CIK 0001389403

Reported 715,000 shares, unchanged from the prior quarter.

Reported value -17.6%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 3.53% This manager · Q3 2022
Shares 715,000 Quarter-end amount reported
Reported value $4,926,000 Fair value at quarter end
Consecutive quarters held 17 Through Q3 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 41636000
2021-12-31 21122000
2022-03-31 17480000
2022-06-30 5977000
2022-09-30 4926000
2022-12-31 4490197
2023-03-31 5791503
2023-06-30 5719997
2023-09-30 5877296
2023-12-31 5734304
2024-03-31 7755048
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for BAUSCH HEALTH COMPANIES INC CO held by Chou Associates Management Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -715,000 (-100.0%) 0 $0 2024-08-14
Q1 2024 Unchanged 715,000 0 (0.0%) 8.7% $7,755,048 2024-05-14
Q4 2023 Unchanged 715,000 0 (0.0%) 7.54% $5,734,304 2024-02-14
Q3 2023 Unchanged 715,000 0 (0.0%) 7.83% $5,877,296 2023-11-14
Q2 2023 Unchanged 715,000 0 (0.0%) 7.24% $5,719,997 2023-08-14
Q1 2023 Unchanged 715,000 0 (0.0%) 8.08% $5,791,503 2023-05-15
Q4 2022 Unchanged 715,000 0 (0.0%) 6.35% $4,490,197 2023-02-14
Q3 2022 Unchanged 715,000 0 (0.0%) 3.53% $4,926,000 2022-11-15
Q2 2022 Reduced 715,000 -50,000 (-6.5%) 4.28% $5,977,000 2022-08-15
Q1 2022 Unchanged 765,000 0 (0.0%) 9.3% $17,480,000 2022-05-16
Q4 2021 Reduced 765,000 -730,000 (-48.8%) 11.05% $21,122,000 2022-02-14
Q3 2021 Unchanged 1,495,000 0 (0.0%) 20.11% $41,636,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

355 managers reported BAUSCH HEALTH COMPANIES INC CO for Q3 2022.

Managers reporting BAUSCH HEALTH COMPANIES INC CO in Q3 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ICAHN CARL C Unchanged 34,721,118 0 1.13% $239,229,000 8 qtrs
PAULSON & CO INC Unchanged 26,439,035 0 13.33% $182,165,000 17 qtrs
FRANKLIN RESOURCES INC Added 18,593,729 +11,230,324 0.07% $128,112,000 15 qtrs
NOMURA HOLDINGS INC Added 16,488,751 +3,134,443 0.47% $114,119,000 17 qtrs
GOLDENTREE ASSET MANAGEMENT LP Added 16,485,382 +2,411,917 7.51% $113,584,000 17 qtrs
VANGUARD GROUP INC Added 10,924,375 +219,279 < 0.01% $75,268,000 17 qtrs
Laurion Capital Management LP Reduced 10,805,532 -377,233 0.44% $74,450,000 16 qtrs
D E Shaw & Co Inc Added 8,227,928 +2,636,551 0.07% $56,691,000 10 qtrs
NATIXIS Added 8,000,000 +7,469,000 0.26% $55,120,000 3 qtrs
MFN Partners Management LP New 6,000,000 +6,000,000 1.87% $41,340,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2022
Filed
November 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
715,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.